Menu
Back to Journals » OncoTargets and Therapy » Volume 7
Original Research
Continuation of bevacizumab and addition of hormone therapy following weekly paclitaxel therapy in HER2-negative metastatic breast cancer
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 10,039 | Dovepress* | 9,324+ | 1,097 | 10,421 | |
| PubMed Central* | 715 | 319 | 1,034 | ||
| Totals | 10,039 | 1,416 | 11,455 | ||
|
*Since 27 November 2014 +Since July 2016 |
|||||
View citations on PubMed Central and Google Scholar